Literature DB >> 23245913

Advances in nanotechnology for the management of coronary artery disease.

June-Wha Rhee1, Joseph C Wu.   

Abstract

Nanotechnology holds tremendous potential to advance the current treatment of coronary artery disease. Nanotechnology may assist medical therapies by providing a safe and efficacious delivery platform for a variety of drugs aimed at modulating lipid disorders, decreasing inflammation and angiogenesis within atherosclerotic plaques, and preventing plaque thrombosis. Nanotechnology may improve coronary stent applications by promoting endothelial recovery on a stent surface utilizing bio-mimetic nanofibrous scaffolds, and also by preventing in-stent restenosis using nanoparticle-based delivery of drugs that are decoupled from stents. Additionally, nanotechnology may enhance tissue-engineered graft materials for application in coronary artery bypass grafting by facilitating cellular infiltration and remodeling of a graft matrix.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2012        PMID： 23245913      PMCID： PMC3566293          DOI： 10.1016/j.tcm.2012.08.009

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN： 1050-1738            Impact factor:   6.677


  40 in total

1.  Serum levels of high-density lipoprotein phospholipids correlate inversely with severity of angiographically defined coronary artery disease.

Authors:  S Lan Hsia; R Duncan; A H Schob; S C Chakko; R Mulingtapang; J L He; G O Perez
Journal:  Atherosclerosis       Date:  2000-10       Impact factor: 5.162

Review 2.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

3.  Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis.

Authors:  Gregory M Lanza; Xin Yu; Patrick M Winter; Dana R Abendschein; Kerry K Karukstis; Michael J Scott; Lori K Chinen; Ralph W Fuhrhop; David E Scherrer; Samuel A Wickline
Journal:  Circulation       Date:  2002-11-26       Impact factor: 29.690

4.  Nobori stent shows less vascular inflammation and early recovery of endothelial function compared with Cypher stent.

Authors:  Lakshmana K Pendyala; Daisuke Matsumoto; Toshiro Shinke; Taizo Iwasaki; Ryota Sugimoto; Dongming Hou; Jack P Chen; Jaipal Singh; Spencer B King; Nicolas Chronos; Jinsheng Li
Journal:  JACC Cardiovasc Interv       Date:  2012-04       Impact factor: 11.195

5.  Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxel.

Authors:  Frank D Kolodgie; Michael John; Charanjit Khurana; Andrew Farb; Patricia S Wilson; Eduardo Acampado; Neil Desai; Patrick Soon-Shiong; Renu Virmani
Journal:  Circulation       Date:  2002-09-03       Impact factor: 29.690

6.  Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits.

Authors:  Haim D Danenberg; Ilia Fishbein; Jianchuan Gao; Jukka Mönkkönen; Reuven Reich; Irith Gati; Evgeny Moerman; Gershon Golomb
Journal:  Circulation       Date:  2002-07-30       Impact factor: 29.690

Review 7.  Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions.

Authors:  Nicholas Kipshidze; George Dangas; Mykola Tsapenko; Jeffrey Moses; Martin B Leon; Michael Kutryk; Patrick Serruys
Journal:  J Am Coll Cardiol       Date:  2004-08-18       Impact factor: 24.094

8.  Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability.

Authors:  Pedro R Moreno; K Raman Purushothaman; Valentin Fuster; Dario Echeverri; Helena Truszczynska; Samin K Sharma; Juan J Badimon; William N O'Connor
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

9.  Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits.

Authors:  Haim D Danenberg; Gershon Golomb; Adam Groothuis; Jianchuan Gao; Hila Epstein; Rajesh V Swaminathan; Philip Seifert; Elazer R Edelman
Journal:  Circulation       Date:  2003-11-10       Impact factor: 29.690

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245
View more
  11 in total

Review 1.  Polymeric Nanostructures for Imaging and Therapy.

Authors:  Mahmoud Elsabahy; Gyu Seong Heo; Soon-Mi Lim; Guorong Sun; Karen L Wooley
Journal:  Chem Rev       Date:  2015-08-04       Impact factor: 60.622

Review 2.  Nanomedicine applied to cardiovascular diseases: latest developments.

Authors:  Virna Margarita Martín Giménez; Diego E Kassuha; Walter Manucha
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-02-15

Review 3.  Nanotechnology in diagnosis and treatment of coronary artery disease.

Authors:  Mahdi Karimi; Hossein Zare; Amirala Bakhshian Nik; Narges Yazdani; Mohammad Hamrang; Elmira Mohamed; Parham Sahandi Zangabad; Seyed Masoud Moosavi Basri; Leila Bakhtiari; Michael R Hamblin
Journal:  Nanomedicine (Lond)       Date:  2016-02-23       Impact factor: 5.307

Review 4.  The baffling human body and the boundless nanomaterial boon-a trap for cancer crab.

Authors:  S Jeelani; G S Asokan; G Anuradha; J Parthiban; T Sivasankari
Journal:  J Clin Diagn Res       Date:  2014-07-20

5.  microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis.

Authors:  Gaetano Santulli
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 6.  Surface engineering at the nanoscale: A way forward to improve coronary stent efficacy.

Authors:  Aleena Mary Cherian; Shantikumar V Nair; Vijayakumar Maniyal; Deepthy Menon
Journal:  APL Bioeng       Date:  2021-06-01

Review 7.  Bioabsorbable stent quo vadis: a case for nano-theranostics.

Authors:  Buket Gundogan; Aaron Tan; Yasmin Farhatnia; Mohammad S Alavijeh; Zhanfeng Cui; Alexander M Seifalian
Journal:  Theranostics       Date:  2014-02-22       Impact factor: 11.556

Review 8.  Nanotechnology, an alternative with promising prospects and advantages for the treatment of cardiovascular diseases.

Authors:  Tao Li; Weitao Liang; Xijun Xiao; Yongjun Qian
Journal:  Int J Nanomedicine       Date:  2018-11-09

Review 9.  Recent Advances in Treatment of Coronary Artery Disease: Role of Science and Technology.

Authors:  Eswar Kandaswamy; Li Zuo
Journal:  Int J Mol Sci       Date:  2018-01-31       Impact factor: 5.923

Review 10.  Nanotechnology and stem cells in vascular biology.

Authors:  Tomasz Jadczyk; Guido Caluori; Wojciech Wojakowski; Zdenek Starek
Journal:  Vasc Biol       Date:  2019-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.